drugset / Trial / NCT02516306

A Study to Evaluate the Safety and Efficacy of EV06 Ophthalmic Solution in Improving Vision in Subjects With Presbyopia

NCT02516306 ↗

Phase 1/2 Completed 75 enrolled Encore Vision, Inc.
RandomizedParallel-groupDouble-blindTreatment

Summary

The purpose of this study is to determine whether EV06 Ophthalmic Solution is safe and effective in improving distance corrected near vision in people who have presbyopia.

Timeline

Start
2015-09-16
Primary completion
2016-03-10
Completion
2016-03-10

Drugs

EvaluationDrugModalityDoseRoute
Subject ARLIPOIC ACID CHOLINE ESTER Small molecule — Topical

Indications